Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone Iodine Efficacy Study
NCT05272254Phase 2Active, not recruiting
- Sponsor
- University of Rochester
- Start
- Sep 2022
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in early childhood caries (ECC) comparing Povidone Iodine with Placebo (2 arms). Primary endpoint: Time from randomization to relapse up to 24 months. Started Sep 2022; status: active, not recruiting.
02
Drugs
povidone-iodine
03
Conditions
early childhood caries (ECC)
Beyond the preview
Go deeper on NCT05272254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05272254.